Nov 28, 2016
New York, 28 Nov – Life-saving medicines and essential lab equipment started to arrive in Sudan last week, thanks to a US$60 million agreement signed between UNDP and the Ministry of International Cooperation and the Ministry of Health this past spring.
The three-year project, which is fully funded by the Government of Sudan, will ensure that people living with cardiovascular, respiratory and renal diseases will now have better access to treatment, including vital medicines to cope with diabetes, gastrointestinal medicines and anti-bacterials among others.
This agreement contributes to supporting Sudan to implement Sustainable Development Goal 3 – “Ensure healthy lives and promote well-being for all at all ages” and UNDP’s corporate Strategic Plan, which aims to strengthen institutions to progressively deliver universal access to basic services.
In the past, Sudan has struggled to overcome the challenges of access to convertible currency as well as restrictions on international banking transactions, making it difficult to ensure vulnerable populations are reached with much-needed medicines. The UNDP partnership reflects a strong governmental commitment to ensure that access to medicine is improved all across Sudan.
An event celebrating the arrival of medicines in Sudan took place on 27 November at the National Medical Supplies Fund where UN Resident and Humanitarian Coordinator and UNDP Resident Representative Marta Ruedas called for greater partnership support to the initiative.
“This innovative approach to delivering medicines, medical and laboratory equipment and consumables to Sudan aims primarily to alleviate the suffering of many patients, and we are therefore looking forward to building more partnerships with potential donors to support this unprecedented endeavor for the benefit of the Sudanese people,” said Ruedas, who was joined by UNDP Country Director Dr. Selva Ramachandran, Minister of Health Mr. Bahr Idriss Abu Garda, and acting Minister of International Cooperation Mr. Osman Ahmed Wash, among others.
For more information, please click here